By Robert Preidt HealthDay Reporter
       
       HealthDay Reporter

MONDAY, May 16, 2022 (HealthDay News) — As the United States mourns a million deaths from COVID-19, a brand new examine signifies the grim tally might have been worse. Use of the Pfizer-BioNTech COVID-19 vaccine prevented greater than 110,000 deaths and 690,000 hospitalizations within the United States in 2021, researchers report.

The vaccine additionally prevented 8.7 million symptomatic instances of an infection and saved greater than $30 billion in well being care prices and greater than $40 billion in misplaced productiveness, the examine authors famous.

“The analyses present that the Pfizer-BioNTech COVID-19 vaccine contributed substantial public well being influence within the U.S. in 2021, and had a deep impact on the trajectory of the pandemic,” stated Manuela Di Fusco, of Pfizer’s well being economics and outcomes analysis group.

The Pfizer vaccine was the primary COVID-19 shot obtainable within the United States. It was given to almost six in 10 folks nationwide who had been absolutely vaccinated in 2021, in response to the U.S. Centers for Disease Control and Prevention.

The findings had been revealed on-line May 15 within the Journal of Medical Economics. All of the examine authors acquired funding from Pfizer both as staff, consultants or staff of companies paid by Pfizer.

Despite the usage of COVID-19 vaccines, the U.S. loss of life toll in the course of the pandemic neared a million final week.

President Joe Biden ordered U.S. flags flown at half-staff Thursday.

“We should stay vigilant towards this pandemic and do every little thing we are able to to save lots of as many lives as attainable,” Biden stated.

In this examine, researchers estimated the influence of the Pfizer vaccine utilizing a mannequin, real-world knowledge and medical trial knowledge.

The mannequin used knowledge on the variety of folks vaccinated, the effectiveness of the vaccine in varied age teams, and the possibilities of being contaminated, creating signs and being hospitalized.

It additionally included the results of lengthy COVID, the variety of working days possible misplaced attributable to short-term sickness and the financial influence of untimely deaths from the illness.

The mannequin didn’t embrace the influence of the extra transmissible Omicron variant that turned the dominant coronavirus pressure on the finish of the examine interval.

Continued

The vaccine “was estimated to stop tens of millions of COVID-19 symptomatic instances, 1000’s of hospitalizations and deaths, and generated billions in societal financial worth within the U.S. in 2021,” Di Fusco stated in a journal information launch.

The findings “spotlight the chance to proceed widespread vaccination uptake to stop COVID-19-related illness and generate societal advantages,” she added.

Numerous limitations might have resulted within the numbers within the examine being underestimates, in response to Di Fusco and colleagues. These embrace not factoring within the vaccine’s potential to cut back transmission of the coronavirus, the severity of instances and the general influence of lengthy COVID .

The researchers additionally famous that their findings cannot be utilized to different COVID-19 vaccines or teams of individuals not particularly analyzed within the examine.

         More data
       

There’s extra on COVID-19 vaccines on the U.S. Centers for Disease Control and Prevention.

SOURCE: Journal of Medical Economics, information launch, May 16, 2022

WebMD News from HealthDay

Copyright © 2013-2022 HealthDay. All rights reserved.

The post Pfizer COVID Vaccine Saved 110,000 American Lives, Study Says appeared first on Healthy and Slim Life.

THURSDAY, March 31, 2022 (HealthDay News) — More than 10,000 American lives have been saved since lung most cancers screening was launched for high-risk people who find themselves over 55 and have a historical past of smoking, a brand new examine exhibits.

But many poor individuals and people in ethnic/racial minority teams are nonetheless lacking out on the advantages of screening for the world’s main reason for most cancers loss of life, researchers famous.

To assess the impacts of the 2013 introduction of low-dose CT scans for high-risk individuals within the United States, the researchers analyzed knowledge from two massive most cancers registries.

They discovered a 3.9% per yr improve in early (stage 1) detection of non-small cell lung most cancers (NSCLC) and a median 11.9% per yr improve in median all-cause survival from 2014 to 2018.

Those will increase within the early detection saved 10,100 U.S. lives, in keeping with the authors of the examine, printed March 30 within the BMJ.

By 2018, stage 1 NSCLC was the predominant prognosis amongst white Americans and people in areas with the very best incomes or highest ranges of training. However, non-white individuals and people in poorer or much less educated areas of the nation remained extra prone to have stage 4 illness at prognosis.

The examine authors additionally decided that different components — together with elevated use of non-screening diagnostic imaging, will increase in over-diagnosis of lung most cancers, and enhancements within the accuracy of figuring out most cancers stage — didn’t play a task within the rise of early lung most cancers diagnoses in the course of the examine interval.

While adoption of lung most cancers screening has been sluggish and screening charges have remained extraordinarily low nationally, the findings “point out the helpful impact that even a small quantity of screening can have on lung most cancers stage shifts and survival on the inhabitants degree,” Alexandra Potter, govt director of the American Lung Cancer Screening Initiative, and fellow examine authors wrote.

They mentioned the latest U.S. Preventive Services Task Force lung most cancers screening tips, which decrease the high-risk screening age to 50, increase screening eligibility for a further 6.5 million Americans, with the best will increase in eligibility occurring amongst girls and racial minorities. The new tips current a chance to “scale back disparities within the early detection of lung most cancers,” the authors famous in a journal information launch.

The examine exhibits the real-world advantages of lung most cancers screening in high-risk individuals, in keeping with an accompanying editorial by Dr. Anne Melzer, an assistant professor of medication within the Division of Pulmonary, Allergy Critical Care and Sleep on the University of Minnesota Medical School, and Dr. Matthew Triplette, an assistant professor on the University of Washington School of Medicine.

But they added that efforts to extend screening “must be prioritized to make sure equitable entry to screening and stop widening disparities within the stage of lung most cancers identified and the survival amongst totally different affected person populations with lung most cancers.”

More info

For extra on lung most cancers screening, see the U.S. National Cancer Institute.

SOURCE: BMJ, information launch, March 30, 2022

The post Screening CT Scans for Lung Cancer Have Saved More Than 10,000 Lives appeared first on Healthy and Slim Life.